Μultiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia

By Galanopoulos A.  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 281-282

Springer Publishing Company

Access to resources Recommend Favorite

Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma

By Li Yangqiu   Chen Shaohua   Yang Lijian   Chen Si   Lin Chunlan   Wang Liang   Lu Yuhong   Geng Suxia   Du Xin   Schmidt Christian A  

Hematology, Vol. 16, Iss. 3, 2011-05 ,pp. : 143-149

Maney Publishing

Access to resources Recommend Favorite

Co-existing chronic myeloid leukaemia and multiple myeloma: rapid response to lenalidomide during imatinib treatment

By Offiah C.  

International Journal of Hematology, Vol. 95, Iss. 4, 2012-04 ,pp. : 451-452

Springer Publishing Company

Access to resources Recommend Favorite

Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117)

By Blair A.   Sutherland H.J.  

Experimental Hematology, Vol. 28, Iss. 6, 2000-06 ,pp. : 660-671

Elsevier

Access to resources Recommend Favorite

Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells - A model for immunotherapy

By Dotti G.   Savoldo B.   Takahashi S.   Goltsova T.   Brown M.   Rill D.   Rooney C.   Brenner M.  

Experimental Hematology, Vol. 29, Iss. 8, 2001-08 ,pp. : 952-961

Elsevier

Access to resources Recommend Favorite